Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Lyra Therapeutics, Inc. (LYRA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 6.8% stake in Lyra Therapeutics, Inc. |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/07/2023 |
SC 13G/A
| Polaris Venture Partners V, L.P. reports a 4.5% stake in Lyra Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Ikarian Capital, LLC reports a 3% stake in Lyra Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| ArrowMark Colorado Holdings LLC reports a 0% stake in Lyra Therapeutics, Inc. |
05/17/2021 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in LYRA THERAPEUTICS, INC. |
02/16/2021 |
SC 13G/A
| Ikarian Capital, LLC reports a 6.3% stake in Lyra Therapeutics, Inc. |
|
|